Research and Development Costs - CPA Far

1. How should Quantum Labs classify the $350,000 of costs incurred in its income statement?
   Answer: Cost of services provided. The costs of R&D activities performed for others under a contract are not considered R&D expenses for the entity performing the work. Instead, these costs are accounted for as the cost of services provided (similar to cost of goods sold) and are matched with the revenue from the contract.
2. TechStart Inc. incurred the following costs during 2024 related to developing a mobile application: Conceptual formulation of alternatives ($75,000); Design of chosen path including coding specifications ($195,000); Development of working model to prove technological feasibility ($285,000); Testing of working model ($65,000); Production of product masters ($145,000); Enhancement of product masters to improve performance ($85,000). Technological feasibility was established when the working model successfully demonstrated all planned features. The application was released to the app store in December 2024. Which costs should be capitalized under the software development guidance?
   Answer: $230,000 Under ASC 985-20, software development costs are capitalized from the point technological feasibility is established until the product is available for general release. Technological feasibility was established after the working model testing was complete. Costs incurred after this point include: production of product masters ($145,000) and enhancement of product masters ($85,000) = $230,000. All costs through testing of the working model are expensed as they occurred before technological feasibility was proven. The December release to the app store marks general availability, ending the capitalization period.
3. What is the total research and development expense Zenith Corp. should report for the year?
   Answer: $400,000 R&D expense is calculated by summing the costs that qualify under GAAP. This includes: all costs for Project Alpha (basic research) of $300,000, plus the costs for Project Beta incurred before technological feasibility ($100,000). The costs for Project Gamma (routine follow-through) are excluded from R&D. The costs for Project Beta after feasibility ($150,000) are capitalized. Total R&D expense = $300,000 + $100,000 = $400,000.
4. DataFlow Inc. spent $2.8 million developing internal-use software for managing customer relationships. The project phases included: planning ($480,000), application development including design and coding ($1,650,000), and post-implementation training and maintenance ($670,000). During the application development phase, $290,000 was spent on data conversion activities that will not be used in the new system, and $180,000 was spent on developing interfaces with legacy systems that will be retired within 18 months. What amount should be capitalized under ASC 350-40?
   Answer: $1,180,000 Under ASC 350-40 for internal-use software, only application development stage costs are capitalized, excluding data conversion and training. From the $1,650,000 application development costs, subtract: data conversion not used in new system ($290,000) and interfaces with systems being retired within 18 months ($180,000). Capitalized amount = $1,650,000 - $290,000 - $180,000 = $1,180,000. Planning costs and post-implementation costs are always expensed.
5. How should the company account for these troubleshooting costs?
   Answer: Expense them as a manufacturing or period cost. Costs incurred during the start-up of commercial production are explicitly excluded from the definition of research and development. These costs, such as troubleshooting production issues, are considered normal operating expenses (either manufacturing overhead or a period cost) and should be expensed as incurred.
6. How should Proton Inc. account for the costs associated with this radical redesign?
   Answer: Expense the costs as research and development. While routine or periodic alterations to existing products are excluded from R&D, significant improvements or radical redesigns that involve new technology fall under the definition of research and development activities. Therefore, these costs should be expensed as R&D as incurred.
7. What is the total amount of costs that should be capitalized as an intangible asset related to the new process?
   Answer: $35,000 Under U.S. GAAP, all internal R&D costs ($500,000) incurred to develop a product or process must be expensed as incurred. However, the legal fees and other direct costs associated with securing a patent ($35,000) are capitalized as an intangible asset (the patent) and amortized over its legal or useful life, whichever is shorter.
8. What is the total amount of costs that Nimbus should capitalize as a software development asset for the year?
   Answer: $230,000 Costs incurred after technological feasibility has been established but before the product is available for general release to customers should be capitalized. This includes coding and testing after feasibility ($200,000) and the production of product masters ($30,000). The total amount to be capitalized is $200,000 + $30,000 = $230,000. Costs incurred before technological feasibility ($50,000 + $120,000) must be expensed as R&D.
9. What is the appropriate accounting treatment for the building's depreciation expense?
   Answer: $50,000 should be allocated to research and development expense. Indirect costs, such as depreciation on a shared facility, should be allocated on a reasonable basis to the functions that benefit from them. A reasonable allocation of the building's depreciation should be made to R&D expense. Allocating based on space occupied is a reasonable method. Therefore, 25% of $200,000, which is $50,000, should be included in R&D expense.
10. Based on the information provided, what is the total amount Nova Corp. should report as research and development expense for the current year?
    Answer: $380,000 Research and development (R&D) expense includes costs directly attributable to R&D activities. The calculation is as follows: Salaries of R&D personnel ($250,000) + Materials consumed in R&D ($90,000) + Depreciation on equipment used exclusively for R&D ($40,000) = $380,000. Marketing research, quality control during commercial production, and legal fees for a patent application are explicitly excluded from R&D expense. Patent legal fees are capitalized as an intangible asset.
11. At which point should the company begin capitalizing the direct costs of materials and services and the payroll costs for employees working on the project?
    Answer: After the preliminary project stage is complete and management has committed to funding the project. For internal-use software, capitalization begins after the preliminary project stage is complete and when management, with the relevant authority, implicitly or explicitly authorizes and commits to funding the project, and it is probable that the project will be completed and the software will be used to perform its intended function. Costs in the preliminary stage are expensed. The 'technological feasibility' milestone applies to software developed for external sale, not internal use.
12. How should ChemCo report the $750,000 of R&D expenditures in its income statement?
    Answer: As research and development expense of $750,000. Under U.S. GAAP, R&D costs are expensed as incurred, regardless of the source of funding. The grant from the government does not change the nature of the expenditure. ChemCo must report $750,000 as R&D expense. The accounting for the grant itself would typically involve recognizing a liability and then recognizing income (e.g., other income) as the related expenses are incurred, but the R&D expense classification is unaffected.
13. What is the correct accounting treatment for the $400,000 payment by Venture Corp.?
    Answer: Expense the entire $400,000 as research and development cost immediately. When R&D is acquired in a transaction other than a business combination (i.e., an asset acquisition), the treatment depends on whether the assets have an alternative future use. If, as in this case, there is no alternative future use, the entire cost must be expensed immediately as research and development expense.
14. Under U.S. GAAP, technological feasibility for a computer software product to be sold to customers is established when the entity has completed which of the following?
    Answer: A detailed program design or a working model. According to ASC 985-20, technological feasibility is established upon completion of a detailed program design or, in its absence, completion of a working model that has been tested to be consistent with the product's design specifications. The other options represent activities that occur either before (business plan) or after (beta testing) the point of technological feasibility.
15. PharmaCorp acquired equipment for $3.2 million that will be used exclusively in research and development activities. The equipment has an estimated useful life of 8 years and no salvage value. Additionally, PharmaCorp purchased materials costing $450,000 that will be consumed in current R&D projects, and materials costing $380,000 that will be stored for use in future R&D projects over the next 3 years. How should these costs be treated in the current year under U.S. GAAP?
    Answer: Capitalize $3.2 million equipment and $380,000 future materials; expense $450,000 current materials Under ASC 730, R&D equipment with alternative future uses beyond the current project should be capitalized and depreciated. The $3.2 million equipment should be capitalized since it will be used over 8 years. Materials for future R&D projects ($380,000) should be capitalized as inventory until consumed. Materials for current projects ($450,000) should be expensed immediately as R&D costs. The equipment depreciation of $400,000 annually would be charged to R&D expense, but the equipment itself is capitalized.
16. What is the appropriate accounting treatment for the cost of this equipment in the year of purchase?
    Answer: Expense the full $220,000 cost as research and development expense. According to U.S. GAAP, the cost of materials, equipment, or facilities that are acquired for a particular R&D project and have no alternative future use should be expensed as R&D in the period the costs are incurred. Since the equipment has no alternative use, its entire cost of $220,000 is included in R&D expense for the year.
17. What amount should TechAdvance Corp capitalize as software development costs for the year ended December 31, 2024?
    Answer: $220,000 Under ASC 985-20, software development costs should be expensed until technological feasibility is established, then capitalized until the product is available for general release. Costs incurred after technological feasibility (Sept 15): Production of product masters ($95,000) + Debugging and refinement ($125,000) = $220,000. All costs before technological feasibility must be expensed, including market research, preliminary proposal, design, coding, and testing. Training materials are expensed as they relate to customer support rather than the software product itself.
18. What amount of expense related to this machine should Apex include in its research and development expense for Year 1?
    Answer: $90,000 When an asset purchased for R&D activities has an alternative future use, its cost should be capitalized. The depreciation on the asset is then allocated to R&D expense for the periods it is used in R&D. The annual straight-line depreciation is calculated as (Cost - Salvage Value) / Useful Life. In this case, it is ($500,000 - $50,000) / 5 years = $90,000 per year. This amount is the R&D expense for Year 1.
19. How should ResearchCorp account for the costs incurred under this government contract arrangement?
    Answer: Record $1,600,000 as contract costs and expense $320,000 as R&D costs When you encounter questions about research and development contracts, the key is distinguishing between costs incurred under the contract versus costs for your own R&D activities. The accounting treatment depends on whether costs are reimbursable and whether you retain technology rights. For the government contract costs, ResearchCorp incurred $1,600,000 in allowable costs (direct materials $450,000 + direct labor $680,000 + overhead $290,000 + subcontractor costs $180,000). Since this is a cost-plus-fixed-fee arrangement, these costs are reimbursable by the government and should be recorded as contract costs, not R&D expenses. The fact that ResearchCorp retains no technology rights doesn't change this - the costs are still recoverable under the contract terms. The $320,000 spent on research beyond the contract scope represents ResearchCorp's own R&D activities using company funds. Since these costs aren't reimbursable and don't result in retained technology rights, they should be expensed as R&D costs under ASC 730. Answer A incorrectly treats all costs as R&D expenses, ignoring the reimbursable nature of contract costs. Answer B wrongly capitalizes contract costs as an asset when they should flow through the income statement. Answer C attempts revenue recognition and uses incorrect cost amounts - the contract costs are $1,600,000, not $1,800,000. Answer D correctly separates the two types of costs: $1,600,000 as contract costs (which will be matched against contract revenue) and $320,000 expensed as R&D. Study tip: Always separate reimbursable contract costs from your own R&D spending - they follow different accounting rules regardless of technology rights retention.
20. How should Mega Corp. account for the $2,000,000 of acquired IPR&D?
    Answer: Capitalize the $2,000,000 as an indefinite-lived intangible asset. In a business combination, acquired in-process research and development (IPR&D) is recognized as an asset separate from goodwill at its acquisition-date fair value. Since the project has not yet reached technological feasibility, it is considered an indefinite-lived intangible asset and is not amortized but is tested for impairment annually until the project is completed or abandoned.

Start this quiz